Stay updated with breaking news from J Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US health regulator said on Thursday it was limiting the use of Johnson & Johnson’s Covid-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback to the shot that has been eclipsed by rivals.
Aspen Pharmacare will switch about half of its Covid-19 vaccine production capacity to other products if demand doesn't pick up within six weeks, its CEO warned.
The US health regulator said on Thursday it was limiting the use of Johnson & Johnson’s Covid-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback to the shot that has been eclipsed by rivals.
San Francisco, Santa Clara, Marin and San Mateo counties had all fallen within the...
WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson...